We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADEA icon
1201
Adeia
ADEA
$3.16B
$693K 0.01%
177,460
+93,487
+111% +$354K
TRTN
1202
DELISTED
Triton International Limited
TRTN
$692K 0.01%
22,894
WSFS icon
1203
WSFS Financial
WSFS
$4.17B
$689K 0.01%
24,023
+2,668
+12% +$70.6K
SMPL icon
1204
Simply Good Foods
SMPL
$989M
$688K 0.01%
37,007
ALGT icon
1205
Allegiant Air
ALGT
$2.36B
$687K 0.01%
6,290
+992
+19% +$90.6K
FMBI
1206
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$687K 0.01%
51,433
+4,962
+11% +$65.8K
SAVE
1207
DELISTED
Spirit Airlines, Inc.
SAVE
$686K 0.01%
38,554
+8,677
+29% +$124K
BEAT
1208
DELISTED
BioTelemetry, Inc.
BEAT
$684K 0.01%
15,132
RLJ icon
1209
RLJ Lodging Trust
RLJ
$1.67B
$682K 0.01%
72,222
GNL icon
1210
Global Net Lease
GNL
$1.9B
$681K 0.01%
40,714
+2,656
+7% +$38K
ADVM
1211
DELISTED
Adverum Biotechnologies
ADVM
$681K 0.01%
3,261
+405
+14% +$71.7K
DNLI icon
1212
Denali Therapeutics
DNLI
$3.97B
$680K 0.01%
28,112
+5,422
+24% +$127K
ITCI
1213
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$679K 0.01%
26,466
+3,201
+14% +$64.8K
CXP
1214
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$678K 0.01%
+51,633
New +$680K
PTLA
1215
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$677K 0.01%
37,639
+4,664
+14% +$64.9K
BIPC icon
1216
Brookfield Infrastructure
BIPC
$5.01B
$676K 0.01%
+22,251
New +$646K
LTC
1217
LTC Properties
LTC
$2.1B
$674K 0.01%
17,896
HMN icon
1218
Horace Mann Educators
HMN
$2.1B
$673K 0.01%
18,329
+1,247
+7% +$43.8K
ZGNX
1219
DELISTED
Zogenix, Inc.
ZGNX
$672K 0.01%
24,868
+5,454
+28% +$150K
EGOV
1220
DELISTED
NIC Inc
EGOV
$668K 0.01%
29,109
OTTR icon
1221
Otter Tail
OTTR
$3.9B
$668K 0.01%
17,221
+933
+6% +$39.3K
HLNE icon
1222
Hamilton Lane
HLNE
$5.91B
$667K 0.01%
9,898
ARI
1223
Apollo Commercial Real Estate
ARI
$886M
$666K 0.01%
67,902
CRNC icon
1224
Cerence
CRNC
$389M
$666K 0.01%
+16,308
New +$468K
CDNA icon
1225
CareDx
CDNA
$2.45B
$666K 0.01%
18,796

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.